In fact, sulforaphane, a chemical activator of Nrf2, restores skin integrity in an epidermolysis bullosa simplex model (created by Krt5 or Krt14 mutation) by activating Krt17 expression [48]. This evidence concerns the gene NFE2L2 and epidermolysis bullosa simplex.